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Abstract The genus Corynebacterium is part of the
phylogeneticgroupnocardioformactinomycetes,which
also includes the genus Mycobacterium. Members of
this phylogenetic group have a characteristic cell
envelope structure, which is dominated by complex
lipids and amongst these, lipoglycans are of particular
interest. The disruption of NCgl2106 in C. glutamicum
resulted in a mutant devoid of monoacylated phospha-
tidyl-myo-inositol dimannoside (Ac1PIM2)r e s u l t i n gi n
the accumulation of Ac1PIM1 and cessation of phos-
phatidyl-myo-inositol (PI) based lipomannan (Cg-LM,
now also termed ‘Cg-LM-A’) and lipoarabinomannan
(Cg-LAM) biosynthesis. Interestingly, SDS-analysis of
the lipoglycan fraction from the mutant revealed the
synthesis of a single novel lipoglycan, now termed
‘Cg-LM-B’. Further chemical analyses established
the lipoglycan possessed an a-D-glucopyranosyluronic
acid-(1 ? 3)-glycerol (GlcAGroAc2) based anchor
which was then further glycosylated by 8–22 mannose
residues,withMan12–20GlcAGroAC2molecularspecies
being the most abundant, to form a novel lipomannan
structure (Cg-LM-B). The deletion of NCgl2106 in
C. glutamicum has now provided a useful strain,
in addition with a deletion mutant of NCgl0452 in
C. glutamicum for the puriﬁcation of Cg-LM-A and
Cg-LM-B.Interestingly,bothCg-LMspeciesinduceda
similar production of TNF-a by a human macrophage
cell line suggesting that the phospho-myo-inositol
residue of the PI-anchor does not play a key role in
lipoglycan pro-inﬂammatory activity.
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Introduction
The characteristic cell envelope of Corynebacterineae
contain mycolic acids, arabinogalactan (AG) and
peptidoglycan, which are covalently linked together
to form the mycolyl–arabinogalactan–peptidoglycan
(mAGP) complex (reviewed in Dover et al. 2004). In
addition to the mAGP complex, other glycolipids,
such as phosphatidyl-myo-inositol (PI) mannosides
(PIMs) and lipoglycans, termed lipomannan (LM) and
lipoarabinomannan (LAM) are characteristic of this
taxon (Besra et al. 1997). LM and LAM possess
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uted to a variety of terminal-capping motifs (Nigou
et al. 2002), including ManLAM (Chatterjee et al.
1993; Khoo et al. 1995) and PILAM (Gilleron et al.
1997). M. tuberculosis and M. leprae produce Man-
LAM, which enables them to infect macrophages and
dendritic cells (Schlesinger et al. 1994; Tascon et al.
2000). ManLAM inhibits the production of proin-
ﬂammatory cytokines, such as IL-12 and TNF-a and
inhibits phagosomal maturation (Knutson et al. 1998;
Nigou et al. 2002; Fratti et al. 2003), while PILAM
from a Mycobacterium smegmatis strain induces the
proliferation of these cytokines (Adams et al. 1993;
Gilleron et al. 1997).
The current model of Corynebacterineae lipogly-
can biosynthesis follows two divergent pathways.
Firstly, PI ? PIM ? LM-A ? LAM (Besra et al.
1997), and secondly, GroAc2 ? GlcAGroAc2 ?
ManGlcAGroAc2 ? LM-B (Tatituri et al. 2007)
(Fig. 1). In the ﬁrst pathway, mycobacterial PI is
glycosylated by a a-mannopyranosyl (Manp) residue,
a reaction catalyzed by PimA (Rv2610c), which
transfers Manp from GDP-mannose to the 2-position
of PI to form PIM1 (Kordulakova et al. 2002). PIM1
is further acylated (Rv2611c; Kordulakova et al.
2003) and mannosylated by a reaction catalyzed by
PimB (Rv0557) resulting in the formation of
Ac1PIM2 (Schaeffer et al. 1999). More recently,
however PimB (now also termed MgtA) in C. glu-
tamicum has been shown to be exclusively involved
in synthesizing a novel mannosylated glycolipid,
1,2-di-O-C16/C18:1-(a-D-mannopyranosyl)-(1 ? 4)-(a-D-
glucopyranosyluronic acid)-(1 ? 3)-glycerol (ManGl-
cAGroAc2) (Tatituri et al. 2007). Previous studies
have shown that RvD2-ORF1 from M. tuberculosis
CDC1551, designated as PimC, catalyzed further
a-mannosylation of Ac1PIM2, resulting in Ac1PIM3
(Kremer et al. 2002). Recently, PimE (Rv1159) has
been shown to be involved in higher PIM biosynthe-
sis and directly in the biosynthesis of Ac1PIM5
(Morita et al. 2006).
The core mannan backbone is glycosylated by
Rv2181 and results in the synthesis of a(1 ? 2)-
Manp linked branches, characteristic of the mannan
backbone in LM and LAM (Kaur et al. 2006).
Recently, Mishra et al. (2007) and Kaur et al.
(2007) reported a novel a-mannosyltransferase, MptA
(Rv2174), involved in the latter stages of LM/LAM
biosynthesis in Corynebacterineae. The mature LM
is then elaborated with arabinose by EmbC to form
LAM (Berg et al. 2005). Recently a novel manno-
syltransferase, MT1671 (and Rv1635c), has been
shown to add terminal Manp residues to the mature
LAM in M. tuberculosis to form ManLAM (Dina-
dayala et al. 2006; Appelmelk et al. 2007).
In this study, we have examined an NCgl2106 null
mutant of C. glutamicum and established that
NCgl2106 is a phosphatidyl-myo-inositol monoman-
noside mannopyranosyltransferase exclusively
involved in the synthesis of Ac1PIM2 from Ac1PIM1,
now termed Cg-pimB0 (Lea-Smith et al. 2008)
(Fig. 1). In addition, the utilisation of this mutant
strain allowed the isolation and chemical analysis of a
novel lipoglycan, now termed Cg-LM-B, based on a
GlcAGroAc2 anchor rather than a PI-based anchor,
which typiﬁes Corynebacterineae LM and LAM.
Moreover, puriﬁcation of Cg-LM-A and Cg-LM-B,
has allowed an evaluation of their pro-inﬂammatory
properties.
Materials and methods
Strains and culture conditions
The wild type of Corynebacterium glutamicum,
ATCC 13032, was grown on either the complex
medium Brain Heart Infusion (BHI) (Difco) or a salt
medium CGXII (Eggeling and Bott 2005)a t3 0 C.
The Escherichia coli strain DH5 was grown on LB at
37C. Kanamycin and ampicillin were used at a
concentration of 25 or 50 lg/ml, wherever appropri-
ate. Samples for lipid analysis were prepared by
harvesting the cells at an optical density 600 nm of
10–15 followed by a saline wash and freeze drying.
Construction of plasmids and strains
To construct the deletion vector pK19mobsacBD2106
crossover PCR was applied with primer pairs
Nout2106/Nin2106 (Nout2106, AATCGGAGATCC
GAGACCGGG; Nin2106, CCCATCCACTAAACTT
AAACATTTTCGGGATGCAGACACAAAGA) (all
primers in 50–30 direction) and Cout2106/Cin2106
(Cout2106, ACCCAGTTGTCAGCGCCTTGAG; Cin
2106, TGTTTAAGTTTAGTGGATGGGCGGTTG
ACCAATATTTTGCAGAG) with C. glutamicum
genomic DNA as template. Both ampliﬁed products
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123were used in a second PCR with primer pairs
Nout2106/Cout2106 to generate a 1025 bp fragment
consisting of sequences adjacent to NCgl2106, which
was made blunt, phosphorylated and ligated with
SmaI-cleaved pK19mobsacB. The chromosomal dele-
tion of NCgl2106 was performed as described
previously using two rounds of positive selection
(Schafer et al. 1994), and its successful deletion
veriﬁed by use of two different primer pairs. Plasmids
were introduced into C. glutamicum by electropora-
tionwithselectiontokanamycinresistance(25 lg/ml)
on BHI. To enable expression of NCgl2106 in the
deletion mutant, NCgl2106 was ampliﬁed using the
primer pair CGCGGATCCAAGGAG ATATAGATA
TGTCTGCATCCCGAAAAACTCTC and CGCGAA
TTCTCATCGTGGTTCACTCTGC. The puriﬁed
PCR fragment was digested with BamHI-EcoRI and
ligated with pEKEx2 (Eikmanns et al. 1991). All
cloned fragments were veriﬁed by sequencing.
Lipid extraction and puriﬁcation of lipoglycans
Polar lipids and apolar lipids were extracted as
described previously (Dobson et al. 1985). The polar
lipid extract was examined by 2D-TLC on aluminum
backed plates of silica gel 60 F254 (Merck 5554), using
CHCl3/CH3OH/H2O (60:30:6, v/v/v) in the ﬁrst direc-
tion and CHCl3/CH3COOH/CH3OH/H2O (40:25:3:6,
Fig. 1 Schematic
representation of MGDAG
and PIM pathway for
lipoglycan synthesis in
Corynebacterianae
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123v/v/v/v) in the second direction. C. glutamicum gly-
colipids were visualized by spraying plates with either
a-naphthol/sulfuricacid, Dittmer&Lester Reagent,or
5% ethanolic molybdophosphoric acid followed by
gentle charring of plates. Glycolipids were further
puriﬁed into individual species by preparative TLC on
10 cm 9 20 cmplasticbackedTLCplatesofsilicagel
60 F254 (Merck 5554), run in chloroform/methanol/
water (60:30:6, v/v/v). The plates were then sprayed
with0.01%1,6-diphenyl-1,3,5-hexatrienedissolvedin
petroleum ether/acetone (9:1 v/v) and the glycolipids
visualized under UV light. Following detection the
plates were re-developed in toluene to remove
diphenyl-1,3,5-hexatriene and the corresponding gly-
colipid bands were scraped from the plates and
extracted from the silica gel using chloroform/
methanol (2:1, v/v). Samples were prepared for
MALDI-TOF-MS as described previously (Tatituri
et al. 2007). Lipoglycans from C. glutamicum strains
were extracted and puriﬁed as described previously
(Nigou et al. 1997; Ludwiczak et al. 2002; Tatituri
et al. 2007).
Permethylation of Cg-LM-B prior
to MALDI-TOF analysis
Permethylation was performed using the sodium
hydroxide procedure as described previously (Dell
et al. 1993). MALDI-TOF and TOF/TOF MS data on
permethylated samples were acquired in the positive
ion mode (M + Na)
+ using a 4800 (Applied Biosys-
tems) mass spectrometer in the reﬂector mode with
delayed extraction. The collision energy was set to
1 kV, and argon was used as collision gas for MS/MS
data collection. Samples were dissolved in methanol,
and 1 ll was mixed at a 1:1 ratio (v/v) with 2,5-
dihydrobenzoic acid (20 mg/ml in 70% methanol in
water) as matrix.
Gas chromatography–mass spectrometry linkage
analysis
Partially methylated alditol acetates were prepared
from permethylated samples for gas chromatogra-
phy–mass spectrometry (GC–MS) linkage analysis as
described (Dell et al. 1993). The partially methylated
alditol acetates were analyzed using a PerkinElmer
Clarus 500 instrument ﬁtted with a RTX-5 column
(30 m 9 0.25-mm internal diameter, Restek Corp.).
The sample was dissolved in hexane and injected
onto the column at 65C. The column was maintained
at this temperature for 1 min and then heated to
290C at a rate of 8C per min.
TNF-a production by human macrophage cell line
THP-1 human monocyte/macrophage cell line was
maintained in continuous culture with RPMI 1640
medium (Lonza), 10% fetal calf serum (Lonza) in an
atmosphere of 5% CO2 at 37C, as non-adherent cells.
Lipoglycans at concentrations of 5 or 15 lg/ml were
added in triplicate to cells (10
5 cells/well) in 96-well
culture plates and then incubated for 16 h at 37C.
Supernatants were assayed for TNF-a by sandwich
ELISA using commercially available kits and accord-
ing to manufacturer’s instructions (R&D Systems).
Results
Construction and growth
of C. glutamicumDpimB0
We found that the gene product of NCgl0452 of
C. glutamicum, respectively its ortholog Rv0557 in
M. tuberculosis, originally termed PimB and now
termed MgtA (Tatituri et al. 2007), primarily acts as
an a-mannosyltransferase to add mannose to GlcAGro-
Ac2 (Tatituri et al. 2007). This study also highlighted
the presence of a lipomannan, now termed Cg-LM-B,
basedonaGlcAGroAc2anchorratherthanaPI-anchor.
Further characterization of Cg-LM-B was ham-
pered due to co-migration and co-elution following
size exclusion chromatography with the PI-based
Cg-LM-A (Tatituri et al. 2007). To investigate the
structureandfunctionofCg-LM-Bfurtherweadopteda
strategy based on the existence of two pathways to
lipoglycan synthesis (Fig. 1) and to identify Cg-pimB0
involved in Ac1PIM2 synthesis whereby disruption
would block C. glutamicum LM/LAM synthesis while
Cg-LM-B would be unaffected. We searched for
unknown glycosyltransferases using nucleotide-acti-
vated sugars. Amongst others we identiﬁed NCgl2106
in the genome of C. glutamicum with orthologs present
in all Corynebacterianeae including Mycobacterium
species.
In order to delete NCgl2106 in the wild type of
C. glutamicum, we constructed the non-replicative
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form C. glutamicum to kanamycin resistance,
indicatingintegrationinitschromosome(Fig. 2a).Loss
of vector was obtained by selection for sucrose-
resistance yielding clones with NCgl2106 deleted. A
PCR analysis with primers hybridizing outside of the
sequences used for strain construction resulted in the
expected fragment of 2159 bp for the wild type and of
1088 bp for the deletion mutant, which was termed
C. glutamicumDpimB0.
Polar lipid analysis
Lyophilised cells were extracted using petroleum-ether
and methanolic saline to recover apolar lipids. Further
processing of the methanolic extract afforded the polar
lipidfraction,whichwasexaminedbytwo-dimensional
thin-layerchromatography(2D-TLC).Theextractfrom
wild type C. glutamicum showed the presence of
ManGlcAGroAc2,G l c A G r o A c 2 (Gl-A) and Ac1PIM2,
by a-naphthol/sulfuric acid staining (Fig. 2b). Surpris-
ingly, while the synthesis of ManGlcAGroAc2 and
GlcAGroAc2 remained unaffected the component cor-
respondingtoAc1PIM2identiﬁedbynegativeionmode
MALDI-MS at m/z 1398 [M-H]
- with the fatty acyl
groupsC16andC18:1(Tatituriet al.2007)wasabsentin
C. glutamicumDpimB0 with the appearance of a new
product, which was sugar (Fig. 2b) and phosphate
positive (data not shown) by speciﬁc staining. This
predominantlipidspotwaspuriﬁedandcorrespondedto
Ac1PIM1, which was conﬁrmed by negative ion mode
MALDI-MSanalysesduetothecharacteristicionatm/z
1236 (M-H)
- (data not shown). Complementation of
C. glutamicumDpimB0 by pEKEx2-Cg-pimB0 restored
the wild type phenotype (Fig. 2b). Altogether, the data
indicatedthatAc1PIM1inC. glutamicumDpimB0 occurs
possibly as a result of inactivation of a phosphatidyl-
myo-inositol mannosyltransferase, presumably which
transfers a mannopyranosyl (Manp) residue fromGDP-
Mannose to the 6-position of Ac1PIM1. In addition this
data also shed further light on the acylation step in PIM
biosynthesis in Corynebacterianeae. The accumulation
of Ac1PIM1 in C. glutamicumDpimB0 showed that the
acylation step (Kordulakova et al. 2003)p r e c e d e st h e
second mannosylation step in PIM biosynthesis, and
results in the formation of Ac1PIM2 (Schaeffer et al.
1999).
Lipoglycans were extracted by reﬂuxing delipi-
dated cells in ethanol, followed by hot-phenol
extraction, protease digestion and dialysis to remove
impurities. The extracted lipoglycans were examined
initially on 15% SDS-PAGE (Fig. 2c). Extracts from
wild type C. glutamicum showed the presence of
Cg-LAM, Cg-LM-A and Cg-LM-B (Tatituri et al.
2007). As expected the lipoglycan extract from
C. glutamicumDpimB0 showed the absence of Cg-LAM
and Cg-LM-A, and the presence of a single species
(Cg-LM-B) by chemical characterization as described
below. Complementation of C. glutamicumDpimB0
by transformation with plasmid pEKEx2-Cg-pimB0
restored the wild type phenotype of Cg-LAM,
Cg-LM-A and Cg-LM-B (Fig. 2c). As predicated,
the inactivation of Cg-PimB0 abolished the synthesis
of Cg-LAM and Cg-LM-A, and provided a strain that
allowed the puriﬁcation of Cg-LM-B for further
chemical and functional characterisation. Cg-LM-B
from C. glutamicumDpimB0 and Cg-LM-A from
C. glutamicumDpimB0 (Tatituri et al. 2007) were
puriﬁed by hydrophobic interaction chromatography
(HIC) and size exclusion chromatography.
Analysis of Cg-LM-B by mass spectrometry
The Cg-LM-B was permethylated prior to detailed
mass spectrometric analysis. During the permethyla-
tion step the acyl groups from the lipoglycan are
liberated and the glycerol hydroxyl groups are
methylated. The MALDI-TOF MS proﬁle of the
permethylated sample in the positive mode showed
no signals for ManGlcAGro (m/z 579) but, interest-
ingly, a series of peaks (M + Na
+) corresponding to
the addition of 4–22 hexose residues to the GlcAGro
core structure. In the lower mass region of the
spectrum, signals consistent with the elongation of
the GlcAGro core were observed at m/z 1191.7,
1395.8 and 1600.0 corresponding to the compositions
Hex4GlcAGro, Hex5GlcAGro and Hex6GlcAGro,
respectively (data not shown). Peaks corresponding
to Hex7GlcAGro and Hex9GlcAGro were absent
from the spectrum. At higher mass, signals were
observed corresponding to a series of HexnGlcAGro
units containing even numbers of hexoses at m/z
2008.2, 2416.4, 2824.6, 3232.8, 3641.0, 4049.2,
4457.2 and 4865.6 with Hex12GlcAGro (m/z
2824.6) being most abundant (Fig. 3a). The low
abundance of signals attributable to components
carrying an odd number (Hex11, 13, 15, 17, 19 and
21) of hexoses (m/z 2620.5, 3028.7, 3436.9, 3849.0,
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1234252.2 and 4660.4), as compared to even numbered,
suggests that the hexose polymer is branched rather
than linear. In addition, there are also signals present
in the MS spectrum attributable to hexose oligomers.
This may result from partial degradation of the
sample during preparation but could also be due to
contamination. Each of the major signals in the
spectrum was subjected to collision induced decom-
position MS/MS (CID-MS/MS) analysis to establish
their structures. For example, MS/MS spectra of the
Fig. 2 Construction of
inframe deletion mutant of
pimB0 in C. glutamicum and
resulting phenotype. (a)
Strategy to delete pimB0 by
use of vector
pK19mobsacBDpimB0 by
two homologous
recombination events with
the wild type chromosome
C. glutamicum (Cg-WT).
The deletion is
demonstrated on the right
via PCR using primer pairs
P5/P6 showing the expected
1088 bp fragment for the
deletion mutant in the lane
marked ‘‘D’’, and that of
2159 bp for the wild type
marked ‘‘W’’. The lane
marked ‘‘St’’ is the standard
consisting of BstEII-
fragments of k-DNA, with
arrowheads positioned at
0.70, 1.37, 2.32, and
3.68 kb. (b) TLC-analysis
of PIM biosynthesis in
C. glutamicum,
C. glutamicumDpimB0 and
C. glutamicumDpimB0
pEKEx2-pimB0. Glycolipids
were visualized by spraying
plates with a-naphthol/
sulfuric acid, followed by
gentle charring of TLC
plates. (c) Lipoglycan
proﬁles of C. glutamicum
strains analyzed using SDS-
PAGE and visualized using
a Pro-Q emerald
glycoprotein stain
(Invitrogen) speciﬁc for
carbohydrates. The major
bands represented by Cg-
LAM, Cg-LM-A, and Cg-
LM-B are indicated. The
four major standard bands
indicated on the side of the
gel represent glycoproteins
of 180, 82, 42 and18 kDa,
respectively
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123signal at m/z 2416, which has the composition
Hex10GlcAGro, showed peaks at m/z 2198, 1994,
1585.6, 1381.5, 1177.5, 769.3 and 361 (Fig. 3b)
which are due to the loss of 1, 2, 4, 5, 6, 8 and 10
hexose units from the molecular ion. The inset to
Fig. 3b shows the likely sequence that is consistent
with this set of fragment ions.
In order to conﬁrm the nature of the hexose units
and linkages, GC/MS analysis of partially methylated
alditol acetates was carried out. This revealed the
presence of terminal mannose, 2 linked mannose, 2,6
linked mannose (data not shown). The presence of
t-Man and 2,6-Man convincingly establishes that the
backbone of the oligomannans is heavily branched.
The relative abundances of t-Man (1.0), 6-Man (0.5)
and 2,6-Man (0.98) are consistent with single man-
nose residues being appended at O-2 to the 6-linked
mannosyl backbone.
TNF-a production by human macrophage cell line
in response to Cg-LMs
PI-anchored lipoglycans, and most particularly LMs,
isolated from other actinomycete genera, including
Fig. 3 MALDI-TOF/TOF
analysis of permethylated
Cg-LM-B [M + Na
+]
MannGlcAGro. (a)M S
spectrum of the dervatized
Cg-LM-B. Unassigned
peaks (*) are due to
permethylation artifacts.
(b) CID-MS/MS analysis
of m/z 2416 (M + Na
+)
Man10GlcAGroAc. A
possible structure and CID
fragmentation pattern of
peak m/z 2416 is depicted in
the cartoon representation,
inset. Circle-mannose;
diamond-glucuronic acid
Antonie van Leeuwenhoek (2008) 94:277–287 283
123mycobacteria, have previously been shown to induce
cytokine production by phagocytic cells (Garton
et al. 2002; Gibson et al. 2004; Quesniaux et al.
2004). We thus investigated the potency of both types
of Cg-LMs to stimulate the release of TNF-a using a
human macrophage cell line. As expected, the
PI-anchored LM, Cg-LM-A, elicited a dose-depen-
dent production of the cytokine (Fig. 4). However
interestingly, the GlcAGroAc2-anchored LM,
Cg-LM-B, was also found to be as stimulatory as
the PI-anchored LM, suggesting that the phospho-
myo-inositol unit of the anchor in LM does not play a
key role in lipoglycan pro-inﬂammatory activity.
Discussion
SDS-PAGE analysis of puriﬁed lipoglycans from
C. glutamicumDpimB0 showed the presence of a
single species, which migrated akin to Cg-LM.
Chemical characterization of this novel species using
MS-MS established it as an oligomer of hyperman-
nosylated oligosaccharides linked to GlcAGroAc2.I t
was previously established that these glycosylated
diacylglycerols function as precursors/anchors for
hyperglycosylated variants, such as the lipomannans,
as found in the case of dimannosyl diacylglycerols in
Micrococcus and lipoteichoic acids (Pakkiri and
Waechter 2005). Moreover, related di- and monoa-
cylglycerols containing glucuronosyl residues have
been well reported in Pseudomonas sp. (Wilkinson
1968) Bacillus cereus T (Minnikin et al. 1971), and
halotolerant bacteria (Stern and Tietz 1971). The data
in relation to Mycobacterium are sparse in regards to
the presence of glycosyl diacylglycerols, except for a
few limited cases, such as a diglucosyl diacylglycerol
(Hunter et al. 1986). In Mycobacterium smegmatis,a
minor glucuronosyl diacylglycerol glycolipid has
been reported (Wolucka et al. 1993), and uronosyl-
containing glycopeptidolipids in Mycobacterium avi-
um (Chatterjee et al. 1987) and Mycobacterium
habana (Khoo et al.1996). Our results also support
our initial hypothesis that ManGlcAGroAc2 also
participates in the biosynthesis of a novel Cg-LM-
like molecule and that the Cg-LM most likely consists
of two components, a minor Cg-LM based on
ManGlcAGroAc2 (Cg-LM-B) and a more abundant
component akin to the characteristic dominant myco-
bacterial PI-based LM (Cg-LM-A) (Tatituri et al.
2007). The presence of a Cg-LM-B type species may
exist in Mycobacterium, based on the identiﬁcation as
mentioned earlier of a minor glucuronosyl diacyl-
glycerol glycolipid (Wolucka et al. 1993), and further
experiments are needed to address this question. It is
also interesting to also note that Cg-LM-A is arabi-
nosylated, yet Cg-LM-B, which possesses a similar
mannan is not arabinosylated. A possibility for this
structural difference maybe that Cg-LM-B is more
heavily branched than Cg-LM-A thereby removing
potential sites for arabinosylation leading to Cg-LAM.
LM-like molecules are powerful pro-inﬂammatory
lipoglycans found in the cell-walls of mycobacteria
and some related actinomycetes genera (Garton et al.
2002; Gibson et al. 2004; Quesniaux et al. 2004),
including Corynebacterium (Tatituri et al. 2007).
They are composed of two parts, a PI anchor to
which is attached an a-D-mannan domain, that both
play a key role in their ability to induce cytokine
production by phagocytic cells. The PI-acylation
pattern is also critical for activity (Gilleron et al.
2006) and the latter is abrogated after deacylation of
LM by alkaline treatment (Gibson et al. 2005). But
the structure of the glycosidic moiety has also been
shown to modulate the pro-inﬂammatory activity of
Fig. 4 TNF-a production by human macrophage cell line in
response to Cg-LMs. Cg-LM-A was isolated and puriﬁed as
described previously (Tatituri et al. 2007) and Cg-LM-B (this
study) were tested at 5 (grey bars) and 15 (black bars) lg/ml
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123the molecule. Indeed, the presence of an arabinan
domain such as in the case of LAM-like molecules
undermines lipoglycan activity by masking the man-
nan domain (Vignal et al. 2003; Gibson et al. 2004).
In addition, LM activity seems also to be modulated
by the presence or not of side chains on the mannan
domain as well as the size of these chains (Gibson
et al. 2005). We have shown that C. glutamicum
contains two types of LM that share a similar mannan
domain but differ by their lipidic anchor, one bearing
a classical PI anchor and the other one based on a
GlcAGroAc2 anchor (Tatituri et al. 2007). In the
present study, aided by two different mutants, which
are selectively affected in the biosynthesis pathway
of each type of LM, we have managed to separate
them. We found that both LMs induced a simi-
lar amount of cytokine secretion by a human
macrophage cell line, indicating that the PI part of
Cg-LM-A does not play a key role in lipoglycan pro-
inﬂammatory activity. Since the completion of these
studies and preparation of manuscript, Lea-Smith
et al. (2008) have reported similar ﬁndings on the
role of Cg-PimB0. However, their study did not
analyze the structural basis of Cg-LM-B in detail and
report on the pro-inﬂammatory properties of this
lipoglycan in comparison to Cg-LM-A, which is now
reported in this present study. Finally, a proposed
hypothetical pathway that takes into account the
potential role of MgtA and PimB0, the accumulation
of Ac1PIM1 and Cg-LM-B, and abrogation of
ManGlcAGroAc2 (Tatituri et al. 2007) and Ac1PIM2
is presented in Fig. 1.
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